(HNR1) Hannover Rück SE - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0008402215
HNR1: Property, Casualty, Life, Reinsurance, Financial,
Hannover Rück SE is a leading global reinsurer, operating in over 150 countries with a strong presence in Europe, the Americas, Asia, and Africa. The company specializes in providing tailored reinsurance solutions across two main segments: Property & Casualty Reinsurance and Life & Health Reinsurance. In the Property & Casualty segment, it offers coverage for a wide range of risks, including natural catastrophes, cyber threats, marine and offshore energy, and aviation. The company also provides structured reinsurance and insurance-linked securities, catering to the growing demand for alternative risk transfer solutions. In the Life & Health segment, Hannover Rück SE delivers risk management solutions for mortality, longevity, disability, and critical illness, as well as group life and retirement reinsurance products.
Hannover Rück SE is part of the Talanx Group, one of Europes largest insurance groups, and has a market capitalization of approximately €32 billion. The company has consistently demonstrated strong profitability, with a return on equity (RoE) of 19.74% and a price-to-earnings (P/E) ratio of 13.75, indicating a balanced valuation relative to its earnings. Its stock, traded under the ticker HNR1 on the XETRA exchange, has shown stability with an average 20-day trading volume of 126,362 shares and a current price of €278.00. The stocks moving averages (SMA 20: €270.66, SMA 50: €264.43, SMA 200: €251.10) suggest a recent upward trend, with the 20-day average above the 50-day average.
Looking ahead, Hannover Rück SE is expected to maintain its strong market position, supported by its diversified portfolio and robust capital position. Over the next three months, the stock is likely to remain in a bullish trajectory, with potential resistance near €285 and support around €265. The average true range (ATR) of €7.02 indicates moderate volatility, suggesting that price fluctuations will remain manageable. With a forward P/E of 13.53, the stock is attractively valued relative to its future earnings potential. Overall, Hannover Rück SE is well-positioned to capitalize on growing demand for reinsurance solutions, particularly in emerging markets and specialty risk segments.
Additional Sources for HNR1 Stock
HNR1 Stock Overview
Market Cap in USD | 38,099m |
Sector | Financial Services |
Industry | Insurance - Reinsurance |
GiC Sub-Industry | Reinsurance |
IPO / Inception |
HNR1 Stock Ratings
Growth Rating | 81.5 |
Fundamental | 49.8 |
Dividend Rating | 2.36 |
Rel. Strength | 0.94 |
Analysts | - |
Fair Price Momentum | 292.45 EUR |
Fair Price DCF | 1035.52 EUR |
HNR1 Dividends
Dividend Yield 12m | 1.22% |
Yield on Cost 5y | 2.48% |
Annual Growth 5y | -21.40% |
Payout Consistency | 61.9% |
HNR1 Growth Ratios
Growth Correlation 3m | 69.8% |
Growth Correlation 12m | 80.3% |
Growth Correlation 5y | 92.7% |
CAGR 5y | 16.00% |
CAGR/Max DD 5y | 0.60 |
Sharpe Ratio 12m | 1.66 |
Alpha | 14.88 |
Beta | 0.447 |
Volatility | 27.37% |
Current Volume | 136.5k |
Average Volume 20d | 125.1k |
As of April 29, 2025, the stock is trading at EUR 274.40 with a total of 136,471 shares traded.
Over the past week, the price has changed by -2.21%, over one month by -0.97%, over three months by +4.89% and over the past year by +21.14%.
Partly, yes. Based on ValueRay Fundamental Analyses, Hannover Rück SE (XETRA:HNR1) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 49.84 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HNR1 as of April 2025 is 292.45. This means that HNR1 is currently overvalued and has a potential downside of 6.58%.
Hannover Rück SE has no consensus analysts rating.
According to ValueRays Forecast Model, HNR1 Hannover Rück SE will be worth about 319.1 in April 2026. The stock is currently trading at 274.40. This means that the stock has a potential upside of +16.3%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 280.9 | 2.4% |
Analysts Target Price | - | - |
ValueRay Target Price | 319.1 | 16.3% |